The Canadian Breakpoint
35 episodes
S4 Ep 9LIVE at the 2025 AMR Symposium: The Public Health Agency of Canada’s AMR Task Force and the Pan Canadian Action Plan with Dr. Kanchana Amuratunga
Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Dr. Kanchana Amuratunga to discuss The Public Health Agency of Canada’s AMR Task Force and the Pan Canadian Action Plan. For more information visit:Canada’s AMR Task Force an Introduction to Canada’s Amr Advisory GroupPan-Canadian Action Plan on Antimicrobial Resistance - Canada.caIDSA All Practice Guidelines: A-Z ListFirstline - Antimicrobial Stewardship Mobile App
S4 Ep 8LIVE at the 2025 AMR Symposium: Canadian Sepsis Strategies
For this episode we go LIVE from The Quay in Toronto at the 2025 AMR Symposium. "Canadian Sepsis Strategies; Optimizing Patient Management with AMS and Equity"Dr. Rupeena Purewal discusses the National Sepsis Action Plan with Dr. Kali Barrett and Ms. Fatima Sheikh, Ph.D.(c). (Sepsis Canada)
S4 Ep 7LIVE at the 2025 AMR Symposium: Canbuild AMR Newfoundland with Dr. Peter Daley
Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Dr. Peter Daley to discuss Canbuild AMR in Newfoundland. For more information visit:Canbuild AMR Audit and Feedback
S4 Ep 6LIVE at the 2025 AMR Symposium: NCCID CAN AMS with Harpa Isfeld-Kiely
Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Harpa Isfeld-Kiely from the NCCID to promote CAN AMS and other NCCID initiatives. For more information visit:National Collaborating Centre for Infectious Diseases – Centre de collaboration nationale des maladies infectieusesCAN AMS! – National Collaborating Centre for Infectious DiseasesAMR – Building AMR awareness togetherAMR: Combat Antimicrobial Resistance
S4 Ep 5LIVE at the 2025 AMR Symposium: AMR in Cystic Fibrosis, A Patient Perspective with Huda Razzak
Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome cystic fibrosis patient and advocate Huda Razzak from Montreal to discuss antimicrobial resistance in cystic fibrosis. For more information visit:We’re changing the cystic fibrosis story.Home - Do Bugs Need Drugs
S4 Ep 4LIVE at the 2025 AMR Symposium: Antimicrobial Resistance and Stewardship with Jason Vanstone
Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Jason Vanstone of Saskatchewan to discuss his projects in AMR research and antimicrobial utilization. For more information, contact Jason at:[email protected] Stewardship Program - About Us | SaskHealthAuthority
S4 Ep 327. S4 Episode 3: IV Amoxicillin Clavulanate
Dr. Rupeena Purewal welcomes back Dr. George Zhanel, Medical Microbiologist in Winnipeg and Research Director for CARA, to expand on The CLEAR Registry and spotlight clear results for IV Amoxicillin Clavulanate.To join CLEAR, email Dr. Zhanel at [email protected] www.can-r.comCanadian IV AmoxClav Product Monograph: 00074544.PDFCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S4 Ep 226. S4 Episode 2: Sepsis
Dr. Rupeena Purewal welcomes Sepsis expert Dr. Alison Fox-Robichaud to discuss the Canadian challenges and initiatives in Sepsis diagnosis and with Sepsis survivors.Sepsis CanadaCanadian Sepsis FoundationCritical Care Canada
S4 Ep 125. S4 Episode 1: ASPIRES 5 Point Antimicrobial Audit
Dr. Rupeena Purewal welcomes Pharmacist Dr. Rosanne Thalakada and Dr. Shaqil Peermohamed to discuss the results of the 5 Point Audit through the ASPIRES Group.ASPIRES - HomeFirstline - Clinical Decision Support PlatformPlanetary Health
S3 Ep 525. S3 Episode 5: LIVE at the AMR Symposium 2024 in Toronto, ON
Dr. Rupeena Purewal is LIVE* at the 2024 AMR Symposium in Toronto, ON and invites Dr. Bradley Langford, Antimicrobial Stewardship and Antimicrobial Resistance Pharmacist Specialist, Infectious Diseases Pharmacist and Assistant Professor, University of Toronto – NCCID, to introduce AMR Aware Canada and their website www.AMRAware.caThis website is in collaboration with the National Collaborating Center for Infectious Diseases (NCCID) Antimicrobial Resistance (AMR) awareness campaign. NCCID: www.nccid.caCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html*This episode was recorded in a live session November 20th 2024.
S3 Ep 424. S3 Episode 4: Emerging Viral Diseases; Are We Ready for the Next Pandemic?
Dr. Rupeena Purewal welcomes back Dr. Jason Kindrachuk for this special halloween episode to discuss Emerging Viral Diseases: Are we ready for the next pandemic?
Bonus Episode: AMR Symposium 2024
bonusFor this special episode, Dr. Rupeena Purewal summarizes the agenda and keynote speakers at this year's 2024 AMR Symposium, empowered by bioMerieux.To register, visit www.amrsymposium.com/registration/ to register to attend virtually or in person November 19th - 20th 2024.Enter coupon code "breakpoint" to receive 25% off your registration fee.
S3 Ep 323. S3 Episode 3: Monkeypox
Dr. Rupeena Purewal welcomes Dr. Jason Kindrachuk whose research focuses on the circulation, transmission and pathogenesis of emerging viruses that pose the greatest threat to global human and animal health, to discuss Monkeypox.
S3 Ep 222. S3 Episode 2: mRNA
Dr. Rupeena Purewal welcomes Dr. Thomas Duchaine , Director of the McGill Center for RNA Sciences, to discuss mRNA.www.thomasduchaine.lab.mcgill.ca
S3 Ep 121. S3 Episode 1: CLEAR Spotlight Review on IV Ceftobiprole
Dr. Rupeena Purewal welcomes back Dr. George Zhanel, Medical Microbiologist in Winnipeg and Research Director for CARA, to expand on The CLEAR Registry and spotlight clear results for IV Ceftobiprole.To join CLEAR, email Dr. Zhanel at [email protected] www.can-r.comCanadian IV Ceftobiprole Product Monograph: Product-Monograph-Zevtera.pdf (avirpharma.com)Canadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S2 Ep 1020. S2 Episode 10: CLEAR Spotlight Review on IV Fosfomycin
Dr. Rupeena Purewal welcomes back Dr. George Zhanel, Medical Microbiologist in Winnipeg and Research Director for CARA, to expand on The CLEAR Registry and CLEAR spotlight review for IV Fosfomycin.To join CLEAR, email Dr. Zhanel at [email protected] www.can-r.comCanadian IV Fosfomycin Product Monograph: [Product Monograph Template - Standard] (ivozfo.com)Canadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S2 Ep 919. S2 Episode 9: Infant Feeding in the Context of HIV
Dr. Rupeena Purewal invites Dr. Sarah Khan, Infectious Disease Specialist and Assistant Professor in the Department of Pediatrics at McMaster University, to discuss infant feeding in the context of HIV.
S2 Ep 818. S2 Episode 8: World AMR Awareness Week: NCCID AMR Awareness Campaign
Dr. Rupeena Purewal invites Dr. Terry Wuerz, Infectious Diseases physician based in Winnipeg, Manitoba, to discuss the National Collaborating Center for Infectious Diseases (NCCID) Antimicrobial Resistance (AMR) Awareness Campaign as well as the Manitoba AMR Alliance.World AMR Awareness Week is November 18-24th. During this time, look for your local landmarks to be lit up in blue for the Go Blue campaign! Take a photo and share on social media using the hashtag #goblueforAMR.Manitoba AMR Alliance Website: www.manitobaamr.caCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caNCCID: www.nncid.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S2 Ep 717. S2 Episode 7: Arexvy® RSV Vaccine
Dr. Rupeena Purewal welcomes Dr. Zain Chagla, associate professor at McMaster University, to discuss the upcoming respiratory season and the RSV vaccine.Canadian Arexvy® Product Monograph: AREXVY English Product Monograph (gsk.com)
S2 Ep 616. S2 Episode 6: CLEAR Registry- Canadian Leadership on antimicrobial rEal life usAge Registry
Dr. Rupeena Purewal invites Dr. George Zhanel, Infectious Diseases and Medical Microbiologist and Research Director for CARA, to discuss the CLEAR registry.To join CLEAR, email Dr. Zhanel at [email protected] www.can-r.comCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S2 Ep 515. S2 Episode 5: Gamification in Medicine
Dr. Rupeena Purewal invites Dr. Shaqil Peermohamed, Infectious Diseases Physician at Vancouver Coastal Health, to discuss gamification in medicine.
S2 Ep 414. S2 Episode 4: CPSP Congenital Syphilis
Dr. Rupeena Purewal invites Dr. Jared Bullard and Dr. Carsten Krueger for a roundtable discussion on Congenital Syphilis.
S2 Ep 313. S2 Episode 3: ASPIRES Program
Dr. Rupeena Purewal invites Dr. Jennifer Grant, Infectious Diseases and Medical Microbiology specialist from Vancouver, BC to discuss the ASPIRES Program.More information about the program can be found here: ASPIRES - Home (vch.ca)Pan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S2 Ep 212. S2 Episode 2: Molecular Diagnostics
Dr. Rupeena Purewal invites Dr. Marthe Charles, Medical Microbiologist and Infectious Diseases Specialist from Vancouver, BC to discuss new molecular diagnostics.Link to some of the diagnostic tools discussed: bioMérieux | Pioneering Diagnostics (biomerieux.com)
S2 Ep 111. S2 Episode 1: Canadian Antimicrobial Resistance Surveillance System Report 2022
Dr. Rupeena Purewal, Canadian Pediatric Infectious Diseases Physician from Saskatoon, Saskatchewan, summarizes the CARSS report for 2022.Find the full report here: Canadian Antimicrobial Resistance Surveillance System (CARSS) Report 2022 - Canada.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S1 Ep 1010. S1 Episode 10: Disseminated Gonorrhea Infections
Dr. Rupeena Purewal invites special guest Dr. David Alexander, PhD Microbiologist in Winnipeg, to discuss Disseminated Gonorrhea Infections.
S1 Ep 99. S1 Episode 9: A Review of Dolutegravir dispersible tab
Dr. Rupeena Purewal invites special guest Dr. Jason Brophy, Infectious Diseases Pediatrician at the Children's Hospital of Eastern Ontario, to review Dolutegravir, an antiretroviral agent for the treatment of HIV.Canadian Dolutegravir Product Monograph: tivicay.pdf (viivexchange.com)
S1 Ep 88. S1 Episode 8: Complicated TB Cases
Dr. Rupeena Purewal invites special guest Dr. Mahli Brindamour, Pediatrician with the Saskatchewan TB Prevention and Control program, to discuss Complicated TB cases.
S1 Ep 77. S1 Episode 7: Tuberculosis Guideline Update for Canada
Dr. Rupeena Purewal invites special guest Dr. Rachel Dwilow, Pediatric Infectious Diseases Physician at Children's Hospital Research Institute of Manitoba, to discuss the Tuberculosis Guideline Update for Canada.
S1 Ep 66. S1 Episode 6: Antimicrobial Stewardship Programs
Dr. Rupeena Purewal welcomes 2 special guests; Pediatric Infectious Diseases Specialist, Dr. Jason Newland in St. Louis as well as Pediatric Infectious Diseases Specialist, Dr. Michelle Mitchell in Milwaukee, to discuss the importance of Antimicrobial Stewardship Programs.Canadian Antimicrobial Resistance Alliance (CARA): www.can-r.comCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caNCCID: www.nncid.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
S1 Ep 55. S1 Episode 5: Cytomegalovirus (CMV)
Dr. Rupeena Purewal invites special guest Dr. Ari Bitnun, Professor of Pediatrics at University of Toronto, to discuss CMV in Canada.
S1 Ep 44. S1 Episode 4: A review of Cabenuva®, an antiretroviral agent for HIV.
Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.
S1 Ep 33. S1 Episode 3: A review of Baloxavir®, an antiviral treatment for influenza A and B.
Dr. Rupeena Purewal, pediatric infectious disease physician, reviews Balxoavir Marboxil®, an oral antiviral medication for treatment of influenza A and influenza B flu. Baloxavir® was approved for medical use in Canada in 2020.Canadian Baloxavir Product Monograph : [Product Monograph Template - Standard] (hres.ca)
S1 Ep 22. S1 Episode 2: Rising Syphilis in Canada
Dr. Rupeena Purewal invites special guest Dr. Ameeta Singh, Infectious Diseases Specialist in Edmonton Alberta, to discuss the rising cases of syphilis in Canada.
S1 Ep 11. S1 Episode 1: A summary of the Canadian Antimicrobial Resistance Surveillance System 2020 Report.
Dr. Rupeena Purewal, Pediatric Infectious Diseases Physician, summarizes the key findings from the 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report. CARSS is Canada's national system for reporting on antimicrobial use and is one of the Public Health Agency of Canada's commitments as part of the Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use.Pan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html